#bioteech

Here’s Why These Two Small Cap Biotechs Just Collapsed

In biotech so far this week, we’ve had plenty of fundamental updates to drive volatility across the space. Here are two of the most talked about as we head into the US open on Wednesday. The two companies in focus are CEL-SCI Corporation (NYSEMKT:CVM) and Galectin Therapeutics Inc (NASDAQ:GALT). Let’s kick things off with the former, CEL-SCI. The company announced on Tuesday that the FDA had put…